JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 96 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $549,000 | +17.1% | 234,294 | +51.4% | 0.01% | 0.0% |
| Q2 2022 | $469,000 | -51.0% | 154,728 | +9.7% | 0.01% | -44.4% |
| Q1 2022 | $958,000 | -25.6% | 141,090 | -8.5% | 0.01% | -25.0% |
| Q4 2021 | $1,288,000 | +48.6% | 154,190 | +32.0% | 0.01% | +33.3% |
| Q3 2021 | $867,000 | -2.0% | 116,784 | -10.2% | 0.01% | 0.0% |
| Q2 2021 | $885,000 | -58.7% | 130,012 | -37.7% | 0.01% | -65.4% |
| Q1 2021 | $2,144,000 | +330.5% | 208,812 | +837.2% | 0.03% | -29.7% |
| Q1 2018 | $498,000 | – | 22,280 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|